STOCK TITAN

ABEO (NASDAQ: ABEO) Form 144: 29,985 restricted shares proposed sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ABEO filed a Form 144 notifying a proposed sale of 29,985 shares of Common Stock. The filing identifies these shares as Restricted Stock dated 06/05/2024 and notes a prior sale of 69,832 shares on 01/22/2026 for $372,267.00.

The notice lists the broker Stifel Nicolaus & Company Inc and indicates Nasdaq as the exchange; timing and proceeds distribution beyond the amounts shown are not detailed in the excerpt.

Positive

  • None.

Negative

  • None.
Proposed sale 29,985 shares Restricted Stock dated 06/05/2024
Recent sale (past 3 months) 69,832 shares Sold 01/22/2026
Proceeds reported $372,267.00 Proceeds tied to 01/22/2026 sale
Exchange Nasdaq Exchange listed in filing
Broker Stifel Nicolaus & Company Inc Broker named on Form 144
Restricted Stock financial
"Restricted Stock | Issuer | 29985 | 06/05/2024"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Form 144 regulatory
"CONTENT TO ANALYZE: Filer Information ... 144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Equity Compensation financial
"Equity Compensation | 29985 | 06/05/2024"
Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ABEO's Form 144 report?

It reports a proposed sale of 29,985 shares of Common Stock. The filing lists these as restricted stock dated 06/05/2024 and notes a prior sale of 69,832 shares on 01/22/2026 for $372,267.00.

Who is the broker handling the ABEO sale listed in Form 144?

The broker listed is Stifel Nicolaus & Company Inc. The filing names Stifel Nicolaus with an address in St. Louis and references Nasdaq as the exchange for the securities.

How many shares were sold by the reporting person in the past three months for ABEO?

The filing shows a sale of 69,832 shares on 01/22/2026. That transaction is reported with proceeds of $372,267.00 in the excerpt.

Are the 29,985 ABEO shares part of equity compensation?

Yes. The excerpt classifies the 29,985 Common Stock shares as Restricted Stock and lists the transaction type as Equity Compensation with a grant/issue date of 06/05/2024.
Abeona Therapeut

NASDAQ:ABEO

View ABEO Stock Overview

ABEO Rankings

ABEO Latest News

ABEO Latest SEC Filings

ABEO Stock Data

241.32M
48.79M
Biotechnology
Pharmaceutical Preparations
Link
United States
CLEVELAND